X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6517) 6517
Book Chapter (83) 83
Magazine Article (14) 14
Book / eBook (5) 5
Conference Proceeding (5) 5
Newsletter (3) 3
Newspaper Article (1) 1
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (4592) 4592
humans (4400) 4400
life sciences & biomedicine (4051) 4051
adenine - analogs & derivatives (3425) 3425
adenine - therapeutic use (2576) 2576
male (2553) 2553
female (2118) 2118
animals (1981) 1981
organophosphonates - therapeutic use (1865) 1865
tenofovir (1668) 1668
adult (1584) 1584
middle aged (1302) 1302
antiviral agents - therapeutic use (1204) 1204
adenine (1114) 1114
hiv infections - drug therapy (1074) 1074
pharmacology & pharmacy (969) 969
hepatitis b, chronic - drug therapy (949) 949
anti-hiv agents - therapeutic use (938) 938
adenine - pharmacology (912) 912
lamivudine - therapeutic use (838) 838
infectious diseases (812) 812
treatment outcome (796) 796
drug therapy, combination (734) 734
adenine - administration & dosage (683) 683
mice (665) 665
rats (650) 650
adenine - adverse effects (625) 625
nicotinamide adenine dinucleotide (586) 586
proteins (572) 572
reverse transcriptase inhibitors - therapeutic use (565) 565
organophosphonates - administration & dosage (516) 516
aged (499) 499
immunology (498) 498
science & technology - other topics (498) 498
biochemistry & molecular biology (493) 493
mutation (492) 492
multidisciplinary sciences (488) 488
virology (484) 484
gastroenterology & hepatology (482) 482
organophosphonates - adverse effects (481) 481
apoptosis (479) 479
medicine (467) 467
research article (465) 465
analysis (462) 462
health aspects (456) 456
hepatitis b (450) 450
organophosphonates (445) 445
drug therapy (444) 444
metabolism (444) 444
research (443) 443
viral load (440) 440
deoxycytidine - analogs & derivatives (439) 439
hepatitis b virus - genetics (438) 438
emtricitabine (423) 423
guanine - analogs & derivatives (422) 422
hiv (419) 419
cell biology (414) 414
oncology (408) 408
abridged index medicus (405) 405
hepatitis b virus - drug effects (399) 399
drug resistance, viral (397) 397
aids/hiv (392) 392
nicotinamide (391) 391
science (391) 391
enzymes (373) 373
lamivudine (373) 373
guanine - therapeutic use (371) 371
adolescent (360) 360
antiviral agents (357) 357
mitochondria (356) 356
deoxycytidine - therapeutic use (355) 355
time factors (351) 351
young adult (351) 351
nad (350) 350
cancer (347) 347
rodents (342) 342
oxidative stress (339) 339
gene expression (336) 336
hepatitis b, chronic - virology (336) 336
anti-hiv agents - adverse effects (332) 332
dna, viral - blood (332) 332
microbiology (328) 328
anti-hiv agents - administration & dosage (327) 327
chemistry (326) 326
human immunodeficiency virus--hiv (326) 326
care and treatment (318) 318
kinases (312) 312
autophagy (311) 311
physical sciences (295) 295
biology (294) 294
organophosphonates - pharmacology (291) 291
deoxyribonucleic acid--dna (288) 288
nadh (282) 282
adenine nucleotides - metabolism (280) 280
hiv infections - virology (274) 274
hepatitis b virus (269) 269
physiological aspects (263) 263
disease models, animal (262) 262
hiv-1 - drug effects (262) 262
risk factors (257) 257
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6222) 6222
Chinese (104) 104
German (91) 91
Japanese (66) 66
Russian (62) 62
French (61) 61
Spanish (55) 55
Italian (25) 25
Korean (19) 19
Portuguese (11) 11
Czech (9) 9
Hungarian (8) 8
Polish (8) 8
Turkish (7) 7
Dutch (4) 4
Ukrainian (4) 4
Croatian (2) 2
Greek (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Mayo Clinic Proceedings, ISSN 0025-6196, 2011, Volume 86, Issue 10, pp. 1009 - 1026
.... This review article is structured to discuss antiviral therapeutics on the basis of these 3 major antiviral categories, with the caveat that some drugs discussed... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Acyclovir - therapeutic use | Foscarnet - pharmacology | Hepatitis C - drug therapy | HIV Infections - epidemiology | Humans | Ganciclovir - analogs & derivatives | Interferons - therapeutic use | Oligopeptides - therapeutic use | Hepatitis - drug therapy | Valacyclovir | Adenine - therapeutic use | Lamivudine - therapeutic use | Ganciclovir - therapeutic use | Proline - pharmacology | Protease Inhibitors - therapeutic use | Guanine - therapeutic use | Oseltamivir - pharmacology | Virus Replication - drug effects | Antiviral Agents - pharmacology | Adenine - analogs & derivatives | Valganciclovir | Organophosphonates - therapeutic use | Proline - analogs & derivatives | Antiviral Agents - therapeutic use | Comorbidity | Interferons - pharmacology | Pyrimidinones - therapeutic use | Acyclovir - pharmacology | Zanamivir - therapeutic use | Herpesviridae Infections - drug therapy | Thymidine - analogs & derivatives | Valine - therapeutic use | Oligopeptides - pharmacology | Telbivudine | Ribavirin - pharmacology | Guanine - analogs & derivatives | Oseltamivir - therapeutic use | Guanine - pharmacology | Hepatitis C - epidemiology | Nucleosides - pharmacology | Ganciclovir - pharmacology | Pyrimidinones - pharmacology | Influenza, Human - drug therapy | Drug Therapy, Combination | Nucleosides - therapeutic use | Acyclovir - analogs & derivatives | Ribavirin - therapeutic use | Valine - analogs & derivatives | Zanamivir - pharmacology | Adenine - pharmacology | Proline - therapeutic use | Organophosphonates - pharmacology | Hepatitis B, Chronic - drug therapy | HIV Infections - drug therapy | Lamivudine - pharmacology | Foscarnet - therapeutic use | Valine - pharmacology | Amantadine - pharmacology | Antiviral agents | Diagnosis | Research | Drug therapy | HIV infection | Health aspects | Index Medicus | Abridged Index Medicus | Symposium on Antimicrobial Therapy
Journal Article
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 05/2012, Volume 142, Issue 6, pp. 1324 - 1334.e3
With the development of effective therapies against human immunodeficiency virus (HIV), hepatitis C virus (HCV) infection has become a major cause of morbidity... 
Gastroenterology and Hepatology | Drug Interaction | HCV | Treatment | HIV | Liver Disease | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Recombinant Proteins - therapeutic use | Coinfection | Antiviral Agents - pharmacokinetics | HIV Infections - epidemiology | Humans | Hepatitis C, Chronic - etiology | Male | Polyethylene Glycols - therapeutic use | Oligopeptides - therapeutic use | Serine Proteinase Inhibitors - therapeutic use | Tenofovir | Deoxycytidine - therapeutic use | Drug Interactions | Homosexuality, Male | Adenine - therapeutic use | Lamivudine - therapeutic use | Anti-HIV Agents - therapeutic use | Dideoxynucleosides - therapeutic use | Hepatitis C, Chronic - epidemiology | Drug Therapy, Combination | Raltegravir Potassium | Substance Abuse, Intravenous - complications | Emtricitabine | Liver Diseases - virology | Antiviral Agents - pharmacology | Adenine - analogs & derivatives | Drug Administration Schedule | Organophosphonates - therapeutic use | Proline - analogs & derivatives | Antiviral Agents - therapeutic use | Liver Diseases - prevention & control | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Pyrrolidinones - therapeutic use | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Disease Progression | Proline - therapeutic use | HIV Infections - etiology | Liver Cirrhosis - virology | Antiviral Agents - adverse effects | HIV Infections - drug therapy | Deoxycytidine - analogs & derivatives | Antiviral agents | Medical colleges | Care and treatment | Liver diseases | Comorbidity | Drug interactions | Mortality | Development and progression | Biological response modifiers | HIV (Viruses) | Hepatitis | Protease inhibitors | Proteases | Hepatitis C virus | Hepatitis C | Health aspects | HIV infection | Index Medicus | Abridged Index Medicus
Journal Article
The Lancet infectious diseases, ISSN 1473-3099, 07/2015, Volume 15, Issue 7, pp. 775 - 784
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 378, Issue 9787, pp. 229 - 237
Summary Background The non-nucleoside reverse transcriptase inhibitor (NNRTI), rilpivirine (TMC278; Tibotec Pharmaceuticals, County Cork, Ireland), had... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Rilpivirine | HIV Reverse Transcriptase - antagonists & inhibitors | Humans | Middle Aged | Male | Anti-HIV Agents - administration & dosage | Nitriles - administration & dosage | Tenofovir | Deoxycytidine - therapeutic use | Nucleotides - therapeutic use | Adenine - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Reverse Transcriptase Inhibitors - therapeutic use | Acquired Immunodeficiency Syndrome - virology | Acquired Immunodeficiency Syndrome - ethnology | Emtricitabine | Nucleosides - therapeutic use | Adenine - analogs & derivatives | Benzoxazines - administration & dosage | Double-Blind Method | Drug Administration Schedule | Organophosphonates - therapeutic use | HIV-1 - drug effects | Pyrimidines - administration & dosage | Anti-HIV Agents - adverse effects | Benzoxazines - adverse effects | Treatment Outcome | HIV-1 - genetics | Acquired Immunodeficiency Syndrome - drug therapy | Benzoxazines - therapeutic use | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | Mutation | Nitriles - adverse effects | Viral Load - drug effects | Deoxycytidine - analogs & derivatives | Nitriles - therapeutic use | Evaluation | Patient outcomes | Clinical trials | Dosage and administration | Drug therapy | HIV infection | Design | Antiretroviral drugs | Corporate sponsorship | Human immunodeficiency virus--HIV | Technological change | Research | Clinical medicine | Drugs | RNA-directed DNA polymerase | Exanthema | antiretroviral therapy | Lamivudine | Lipids | Nucleotides | Regression analysis | Efavirenz | CD4 antigen | nucleosides | Algorithms | Hospitals | non-nucleoside reverse transcriptase inhibitors | Abacavir | Zidovudine | Pharmaceuticals | Index Medicus | Abridged Index Medicus
Journal Article
Antimicrobial agents and chemotherapy, ISSN 1098-6596, 05/2012, Volume 56, Issue 5, pp. 2305 - 2313
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2014, Volume 14, Issue 7, pp. 581 - 589
Journal Article
7.